01—Abstract
Summary
Summary of the 8-K filed May 1, 2024. Cited figures are marked; the original filing is the authoritative source.
CVS Health reported first-quarter 2024 results on May 1, 2024 that were sharply weaker than the prior year, and it cut its full-year 2024 guidance substantially.
Total revenues rose 3.7% to $88.4 billion, but GAAP diluted EPS fell to $0.88a from $1.65 and Adjusted EPS fell to $1.31 from $2.20. Adjusted operating income declined 32.3% to $2.96 billion. The decline was driven mainly by the Health Care Benefits segment, where the medical benefit ratio (MBR) rose to 90.4% from 84.6% on higher Medicare utilization, the impact of lower 2024 Medicare Advantage star ratings, and unfavorable prior-year development.
Segment adjusted operating income there fell 59.9%. Management revised 2024 guidance: GAAP diluted EPS to at least $5.64b (from at least $7.06), Adjusted EPS to at least $7.00 (from at least $8.30), and cash flow from operations to at least $10.5 billion (from at least $12.0 billion). The revision assumes the majority of the first-quarter Medicare utilization pressure persists through the rest of 2024.
The CEO said the company remains confident in its strategy and has a pathway to address the near-term Medicare Advantage challenges. Other pressures included a 9.7%c decline in Health Services revenue after the loss of a large PBM client, and interest expense up 21.6% from debt raised to fund the Signify Health and Oak Street Health acquisitions. Pharmacy & Consumer Wellness was a relative bright spot, with adjusted operating income up 3.8%.
For investors, the central question is whether the Medicare Advantage cost pressure is temporary or structural. The guidance cut assumes it persists, so the reset depends on medical cost trends and Medicare Advantage pricing and star-rating recovery. Cash generation also weakened, with operating cash flow of $4.9 billiond in the quarter versus $7.4 billion a year earlier.
02—Key points
Key Highlights
- Adjusted EPS fell 40.5% year over year to $1.31 from $2.20, and GAAP diluted EPS fell to $0.88 from $1.65.
- Full-year 2024 Adjusted EPS guidance was cut to at least $7.00 from at least $8.30, a reduction of about 16%.
- Full-year 2024 GAAP diluted EPS guidance was cut to at least $5.64 from at least $7.06, and operating cash flow guidance was lowered to at least $10.5 billion from at least $12.0 billion.
- Health Care Benefits MBR rose to 90.4% from 84.6%, driven by Medicare utilization, lower 2024 Medicare Advantage star ratings, and unfavorable prior-year development; segment adjusted operating income fell 59.9%.
- Total revenues grew 3.7% to $88.4 billion, led by Health Care Benefits (+24.6%) and Pharmacy & Consumer Wellness (+2.9%), though Health Services revenue fell 9.7% after a large client loss.
- Operating cash flow was $4.9 billion, down from $7.4 billion, and interest expense rose 21.6% to $716 million, reflecting acquisition-related debt.
- Medical membership rose 1.1 million to 26.8 million in the quarter, including 493,000 individual exchange members, partly offsetting the margin pressure.
03—Questions
Frequently Asked Questions
Why did CVS cut its 2024 earnings guidance?
Management said first-quarter Medicare utilization pressure in the Health Care Benefits segment was higher than expected. The revised guidance assumes most of that pressure persists through 2024. Contributing factors included the impact of lower 2024 Medicare Advantage star ratings and unfavorable prior-year claims development.
How much did profitability decline in the first quarter?
Adjusted operating income fell 32.3% to $2.96 billion from $4.37 billion. Adjusted EPS fell to $1.31 from $2.20, and GAAP diluted EPS fell to $0.88 from $1.65. The Health Care Benefits segment accounted for most of the decline, with its adjusted operating income down 59.9%.
Which business segments performed well, and which struggled?
Pharmacy & Consumer Wellness was the strongest, with adjusted operating income up 3.8% on higher prescription volume, vaccinations, and better drug purchasing. Health Care Benefits struggled because of Medicare cost pressure. Health Services adjusted operating income fell 18.9%, driven by pricing pressure, a lost large client, and lower 340B contributions.
Is the Medicare Advantage problem a one-time issue or a longer-term concern?
The filing does not provide a definitive answer. Management's revised guidance assumes the majority of the utilization pressure persists throughout 2024, and the CEO said the company has a pathway to address the near-term Medicare Advantage challenges. Investors should watch future medical cost trends, Medicare Advantage star-rating recovery, and pricing in upcoming periods.
What does the reduced cash flow outlook mean for shareholders?
Operating cash flow guidance was lowered to at least $10.5 billion from at least $12.0 billion, and first-quarter operating cash flow fell to $4.9 billion from $7.4 billion. Lower cash generation could limit flexibility for buybacks, dividends, and debt repayment. The company repurchased $3.0 billion of stock in the quarter and paid $840 million in dividends, which together exceeded operating cash flow.
04—Continue